Funding

bit.bio

United Kingdom · Biotech

Creates functional, human-relevant cells and models for research, drug discovery, and development

Visit bit.bioFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series C$50MM&G Investments — Role not disclosed

Investors

M&G InvestmentsSeries C

Coverage

Jan 9, 2026bit.bio · Series C

Similar companies

Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
iCUREXKagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.¥140M · Series A first close: equity and debt
Sourcesbit.bio ↗